10,963
edits
Gynopedia needs your support! Please consider contributing content, translating a page, or making a donation today. With your support, we can sustain and expand the website. Gynopedia has no corporate sponsors or advertisers. Your support is crucial and deeply appreciated.
Maputo: Difference between revisions
Jump to navigation
Jump to search
→Medications & Vaccines
| Line 76: | Line 76: | ||
===Laws & Social Stigmas=== | ===Laws & Social Stigmas=== | ||
Regarding HPV, the wide adoption of vaccination is important in all countries, particularly Mozambique. This is because women in sub-Saharan Africa have the highest rate of cervical cancer; it is the main cause of cancer for women in the region. Studies have shown that, when young women are informed about the health benefits of the HPV vaccine, the great majority of Mozambican women want the vaccine.<ref>[https://www.eurekalert.org/pub_releases/2018-06/bifg-agm060418.php A great majority of Mozambican adolescent girls are willing to be vaccinated against HPV]</ref> | |||
===What to Get & Where to Get It=== | ===What to Get & Where to Get It=== | ||
* You can find the '''HPV vaccine''' in Mozambique. There is also a nationwide vaccination pilot program, as of December 2018.<ref>[https://hpvcentre.net/statistics/reports/MOZ.pdf Human Papillomavirus and Related Diseases Report]</ref> | |||
* There are demonstration projects for '''PrEP (pre-exposure prophylaxis)''' in Mozambique. They are meant to test the use of options in PrEP in real world settings, rather than in trial sites. For more information, you can contact PEPFAR, Médecins Sans Frontieres, [https://icap.columbia.edu/where-we-work/mozambique/ ICAP at Columbia University], or BMGF through WHO. You can also check out this [https://www.prepwatch.org/wp-content/uploads/2018/04/Mozambique_PrEP_Studies_Apr2018.pdf sheet on projects]. | * There are demonstration projects for '''PrEP (pre-exposure prophylaxis)''' in Mozambique. They are meant to test the use of options in PrEP in real world settings, rather than in trial sites. For more information, you can contact PEPFAR, Médecins Sans Frontieres, [https://icap.columbia.edu/where-we-work/mozambique/ ICAP at Columbia University], or BMGF through WHO. You can also check out this [https://www.prepwatch.org/wp-content/uploads/2018/04/Mozambique_PrEP_Studies_Apr2018.pdf sheet on projects]. | ||